By centering this conversation on value, the decision will align all parties around a shared goal: lasting improvements in health
The difference between a research protocol that delivers consistent results and one that fails unpredictably often comes down to this exact distinction: managing the risks that actually matter rather than the ones that look dramatic
Beyond its direct role in neutralizing free radicals, glutathione is the indispensable engine driving Phase 2 liver detoxification
Semaglutide is of great benefit to diabetic patients with chronic kidney disease (CKD), significantly reducing the risk of renal events According to the full results of the FLOW trial, in patients with type 2 diabetes and chronic kidney disease (CKD), Semaglutide substantially reduces the risk of major kidney events, cardiovascular disease (MACE), and all-cause death, while also slowing the loss of kidney function
The Therapeutic Goods Administration (TGA) last year issued firm advice to GPs to not initiate new patients on Ozempic due to its short supply, and that is showing no signs of easing any time soon